Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 5, 2009, Pages 736-740

  Agrawal, Arpana ^a   Wetherill, Leah ^b   Dick, Danielle M ^c   Xuei, Xiaoling ^b   Hinrichs, Anthony ^a   Hesselbrock, Victor ^d   Kramer, John ^e   Nurnberger Jr , John I ^b   Schuckit, Marc ^f   Bierut, Laura J ^a   Edenberg, Howard J ^b   Foroud, Tatiana ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Association; Cannabis dependence; CNR1; COGA; Pedigree disequilibrium test

Indexed keywords

CANNABINOID 1 RECEPTOR; DRONABINOL;

ADULT; AGED; ARTICLE; CANNABIS ADDICTION; CHROMOSOME 6Q; CNR1 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE STRUCTURE; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MARIJUANA ABUSE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, CANNABINOID, CB1; YOUNG ADULT;

CANNABIS;

EID: 67649445894     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30881     Document Type: Article

References (41)

1. Agrawal A, Lynskey M. 2006. The genetic epidemiology of cannabis use, abuse and dependence: A review. Addiction 101:801-812. (Pubitemid 43727514)
2. Agrawal A, Lynskey MT, Madden PA, Bucholz KK, Heath AC. 2007. A latent class analysis of illicit drug abuse/dependence: Results from the National Epidemiological Survey on Alcohol and Related Conditions. Addiction 102:94-104. (Pubitemid 46006475)
3. Agrawal A, Hinrichs A, Dunn G, Bertelsen S, Dick D, Saccone SF, Saccone NL, Grucza R, Wang JC, Cloninger CR, Edenberg H, Foroud T, Hesselbrock V, Kramer J, Bucholz K, Kuperman S, Nurnberger J, Porjesz B, Schuckit M, Goate A, Bierut L. 2008a. Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) Sample. Drug Alcohol Depend 93:12-20. (Pubitemid 350236585)
4. Agrawal A, Pergadia ML, Saccone SF, Lynskey MT, Wang JC, Martin NG, Henders A, Campbell M, Garcia R, Broms U, Todd RD, Goate A, Rice J, Kaprio J, Heath AC, Montgomery GW, Madden PA. 2008b. An autosomal linkage scan for cannabis use disorders in the nicotine addiction genetics project. Arch Gen Psychiatry 65:713-721. (Pubitemid 351787242)
5. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
7. Begleiter H, Reich T, Hesselbrock V, Porjesz B, Li TK, SchuckitM,Edenberg H, Rice JP. 1995. The collaborative study on the genetics of alcoholism. Alcohol Health Res World 19:228-236.
8. Benyamina A, Lecacheux M, Blecha L, Reynaud M, Lukasiewcz M. 2008. Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. Expert Rev Neurother 8:479-491.
9. Bierut LJ, Dinwiddie SH, Begleiter H, Crowe RR, Hesselbrock V, Nurnberger JI Jr, Porjesz B, Schuckit MA, Reich T. 1998. Familial transmission of substance dependence: Alcohol, marijuana, cocaine, and habitual smoking: A report from the Collaborative Study on the Genetics of Alcoholism. Arch Gen Psychiatry 55:982-988. (Pubitemid 28506839)
10. Boehnke M. 1991. Allele frequency estimation from data on relatives.AmJ Hum Genet 48:22-25.
11. Bucholz KK, Cadoret RJ, Cloninger RC, Dinwiddie SH, Hesselbrock V, Nurnberger JI, Reich T, Schmidt I, Schuckit MA. 1994. A new, semi-structured psychiatric interview for use in genetic linkage studies. J Stud Alcohol 55:149-158.
12. Cahill K, Ussher M. 2007. Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database Syst Rev Oct 17(4):CD005353. (Pubitemid 351805177)
13. Chen X, Williamson VS,AnSS, Hettema JM, Aggen SH, NealeMC,Kendler KS. 2008. Cannabinoid receptor 1 gene association with nicotine dependence. Arch Gen Psychiatry 65:816-824. (Pubitemid 351957707)
14. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. 2004. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 291:2114-2121. (Pubitemid 38580155)
15. Compton WM, Conway KP, Stinson FS, Colliver JD, Grant BF. 2005. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 66:677-685. (Pubitemid 40942412)
16. Copeland J. 2006. Cannabis use, depression and public health. Addiction 101:1380. (Pubitemid 44337757)
17. Covault J, Gelernter J, Kranzler H. 2001. Association study of cannabinoid receptor gene (CNR1) alleles and drug dependence. Mol Psychiatry 6:501-5502. (Pubitemid 32772558)
18. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. 2005. Efficiency and power in genetic association studies. Nat Genet 37:1217-1223. (Pubitemid 41568704)
19. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25:115-121. (Pubitemid 37064867)
20. Gelfand EV, Cannon CP. 2006. Rimonabant: A selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors. Expert Opin Investig Drugs 15:307-315. (Pubitemid 43338150)
21. Grant BF. 1995. Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. J Subst Abuse 7:481-497. (Pubitemid 26080618)
22. Grant BF, Kaplan K, Shepard J, Moore T. 2003. Source and Accuracy Statement for Wave 1 of the 2001-2002 of the National Epidemiologic Survey on Alcohol and Related Conditions. National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
23. Heller D, Schneider U, Seifert J, Cimander KF, Stuhrmann M. 2001. The cannabinoid receptor gene (CNR1) is not affected in German I.V. drug users. Addict Biol 6:183-187. (Pubitemid 32436734)
24. Herman AI, Kranzler HR, Cubells JF, Gelernter J, Covault J. 2006. Association study of the CNR1 gene exon 3 alternative promoter region polymorphisms and substance dependence. Am J Med Genet Part B 141B: 499-503. (Pubitemid 44024444)
25. Hesselbrock M, Easton C, Bucholz KK, Schuckit M, Hesselbrock V. 1999. A validity study of the SSAGA-A comparison with the SCAN. Addiction 94:1361-1370. (Pubitemid 29433794)
26. Hopfer CJ, Young SE, Purcell S, Crowley TJ, Stallings MC, Corley RP, Rhee SH, Smolen A, Krauter K, Hewitt JK, Ehringer MA. 2006. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Am J Med Genet Part B 141B:895-901. (Pubitemid 44905444)
27. Hutchison KE, Haughey H, Niculescu M, Schacht J, Kaiser A, Stitzel J, Horton WJ, Filbey F. 2008. The incentive salience of alcohol: Translating the effects of genetic variant in CNR1. Arch Gen Psychiatry 65:841-850. (Pubitemid 351957709)
28. Jagerovic N, Fernandez-Fernandez C, Goya P. 2008. CB1 cannabinoid antagonists: Structure-activity relationships and potential therapeutic applications. Curr Top Med Chem 8:205-230. (Pubitemid 351795770)
29. Kendler KS, Prescott CA. 1998. Cannabis use, abuse, and dependence in a population-based sample of female twins. Am J Psychiatry 155: 1016-1022. (Pubitemid 28357724)
30. Li T, Liu X, Zhu ZH, Zhao J,HuX, BallDM,Sham PC, Collier DA. 2000.No association between (AAT)n repeats in the cannabinoid receptor gene (CNR1) and heroin abuse in a Chinese population. Mol Psychiatry 5:128-130. (Pubitemid 30229425)
31. Martin ER, Bass MP, Kaplan NL. 2001. Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 68:1065-1067. (Pubitemid 32289752)
32. Mechoulam R, Hanus L, Martin BR. 1994. Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48:1537-1544. (Pubitemid 24336778)
33. Merikangas KR, Stolar M, Stevens DE, Goulet J, Preisig MA, Fenton B, Zhang H, O'Malley SS, Rounsaville BJ. 1998. Familial transmission of substance use disorders. Arch Gen Psychiatry 55:973-979. (Pubitemid 28506838)
34. Nides M. 2008. Update on pharmacologic options for smoking cessation treatment. Am J Med 121:S20-S31.
35. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63: 259-266.
36. Onaivi ES, Leonard CM, Ishiguro H, Zhang PW, Lin Z, Akinshola BE, Uhl GR. 2002. Endocannabinoids and cannabinoid receptor genetics. Prog Neurobiol 66:307-344. (Pubitemid 34518288)
37. Stinson FS, Ruan WJ, Pickering R, Grant BF. 2006. Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity. Psychol Med 36:1447-1460. (Pubitemid 44355980)
38. Treatment Episode Data Set (TEDS). 2003. Substance Abuse Treatment Admissions by Primary Substance of Abuse, According to Sex, Age Group, Race, and Ethnicity, funded by the Substance Abuse and Mental Health Services Administration, DHHS. The latest data are available at 800-729-6686 or online at www.samhsa.gov.
39. Tsuang MT, Bar JL, Harley RM, Lyons MJ. 2001. The Harvard Twin Study of Substance Abuse: What we have learned. Harv Rev Psychiatry 9:267-279. (Pubitemid 33010369)
40. Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR. 2004. Human cannabinoid receptor 1: 5′ exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse. Mol Psychiatry 9:916-931. (Pubitemid 39381956)
41. Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J. 2007. CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 62:616-626. (Pubitemid 47314382)